Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | BCR | P11274 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2629462 | 0.85 | ALDH1A1 (0.48) | CYP3A4HPGDPTPN1POLBKMT2A | |
| SCHEMBL31439156 | 0.80 | MAPK1 (0.50) | CYP3A4POLBKMT2AMAPTMAPK1 | |
| SCHEMBL25955631 | 0.80 | MAPK1 (0.50) | CYP3A4POLBKMT2AMAPTMAPK1 | |
| SCHEMBL16010550 | 0.79 | CYP3A4 (0.43) | CYP3A4HPGDKMT2AMCL1GAA | |
| SCHEMBL29427938 | 0.79 | CYP3A4 (0.43) | CYP3A4HPGDKMT2AMCL1GAA | |
| SCHEMBL16018014 | 0.78 | CYP3A4 (0.47) | CYP3A4HPGDPTPN1POLBMAPK1 | |
| SCHEMBL11974262 | 0.78 | ALDH1A1 (0.42) | CYP3A4HPGDPOLBKDM4EGAA | |
| SCHEMBL20375023 | 0.76 | TAAR1 (0.41) | CYP3A4HPGDPTPN1ALDH1A1ELANE | |
| SCHEMBL3060235 | 0.74 | SELL (0.46) | POLBKMT2AMAPTMCL1KDM4E | |
| SCHEMBL10106588 | 0.74 | CYP3A4 (0.62) | CYP3A4HPGDPTPN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140256830-A1 | RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE | UNILEVER N.V. (NL) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256830-A1 | RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE | NQO1, RBP4, KEAP1 | CYP3A4 1742/4885HPGD 234/4885PTPN1 3204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.